Ciprofloxacin as broad-spectrum empiric therapy-are fluoroquinolones still viable monotherapeutic agents compared with β-lactams: Data from the MYSTIC Program (US).

Ciprofloxacin as broad-spectrum empiric therapy–are fluoroquinolones still viable monotherapeutic agents compared with β-lactams: Data from the MYSTIC Program (US) by Jones RN and Pfaller MA published in Diagn. Microbiol. Infect. Dis. 2002; 42 (3): 213-215